DGAP-News: Foregoing the use of external consultants brings millions in savings: STADA establishes IT shared service center for the Group
(firmenpresse) - DGAP-News: STADA Arzneimittel AG / Key word(s): Miscellaneous
Foregoing the use of external consultants brings millions in savings:
STADA establishes IT shared service center for the Group
09.09.2013 / 10:31
---------------------------------------------------------------------
Press release
Foregoing the use of external consultants brings millions in savings:
STADA establishes IT shared service center for the Group
Bad Vilbel/Belgrade, September 9, 2013 - In future, the STADA Group will
bring together a significant portion of its IT services in its own shared
service center and, through the elimination of external consulting, will
save a substantial share of the previous costs. STADA IT SOLUTIONS DOO will
be established specifically for this purpose. The company, which will only
provide intercompany services, will be part of Hemofarm A.D. a wholly-owned
subsidiary of the STADA Group in Serbia. Approximately 85 employees at the
Serbian Hemofarm locations in Vrsac and Belgrade will be focused primarily
on the implementation of SAP and Microsoft projects and the corresponding
support for the entire Group. These projects include SAP roll-outs,
upgrades and the introduction of new Sharepoint solutions.
'With STADA IT SOLUTIONS we have found a way to save millions every year
whilst at the same time not just safeguarding jobs but also creating new
ones', explains Angela Weißenberger, CIO of the STADA Group. 'The great
expertise and experience of our Serbian IT colleagues from Hemofarm puts us
in a position to have the implementation and support of SAP and Microsoft
projects in the Group performed by our own employees in future and to
dispense with the use of costly external consultants. Thus from 2014 we
will realize net cost savings of over two million euros in the IT budget,
based on the present workload and cost volumes. From 2015 we even calculate
that we will make annual savings of significantly more than three million
euros.'
In future the approximately 60 employees of what is currently Hemofarm IT
will be part of the newly established STADA IT SOLUTIONS. As the new shared
service center will take over projects for the entire STADA Group, the
capacity will be increased, creating approximately 25 additional jobs.
'The consistent utilization of the cost advantages offered by the Serbian
location which at the same time offers a very high level of quality allows
the entire Group to benefit from STADA IT SOLUTIONS', says Weißenberger.
'This is a good example of the positive effects, also in terms of costs,
arising from STADA consistently pursuing its internationalization strategy.
About STADA Arzneimittel AG and Hemofarm A.D.:
STADA Arzneimittel AG is a publicly-listed company with headquarters in Bad
Vilbel, Germany. STADA consistently focuses on a multi-pillar strategy of
generics and branded products (OTC) with an increasingly international
market orientation. The Group traditionally has a strong presence in Europe
and is the only independent generics producer in Germany. Worldwide, STADA
is one of the five leading companies in the generics industry and is
represented in more than 30 countries with approximately 50 subsidiaries.
Branded products such as Mobilat, Grippostad and Ladival are among the
highest selling in their product category in Germany. In financial year
2012, STADA achieved Group sales of Euro 1.837,5 million, adjusted earnings
before interest, taxes, depreciation and amortization (EBITDA) of Euro
367.5 million and adjusted net income of Euro 147.9 million. As of December
31, 2012, STADA employed 7,761 people worldwide. Since 2006 Hemofarm A.D.
is a wholly-owned subsidiary of the STADA Group. It is the leading generic
pharmaceutical company in Serbia and region and the biggest exporter of
drugs from the country, Hemofarm is present in more than 30 countries with
its wide offer of efficient, high-quality products.
For more information, please contact:
STADA Arzneimittel AG
Media Relations
61118 Bad Vilbel
Tel.: +49(0) 6101 603-165
Fax: +49(0) 6101 603-506
e-Mail: press(at)stada.de
End of Corporate News
---------------------------------------------------------------------
09.09.2013 Dissemination of a Corporate News, transmitted by DGAP - a
company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------
Language: English
Company: STADA Arzneimittel AG
Stadastraße 2-18
61118 Bad Vilbel
Germany
Phone: +49 (0)6101 603- 113
Fax: +49 (0)6101 603- 506
E-mail: communications(at)stada.de
Internet: www.stada.de
ISIN: DE0007251803, DE0007251845,
WKN: 725180, 725184,
Indices: MDAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime
Standard); Freiverkehr in Berlin, Hamburg, Hannover,
München, Stuttgart
End of News DGAP News-Service
---------------------------------------------------------------------
229536 09.09.2013
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 09.09.2013 - 10:31 Uhr
Sprache: Deutsch
News-ID 294459
Anzahl Zeichen: 6644
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 349 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Foregoing the use of external consultants brings millions in savings: STADA establishes IT shared service center for the Group"
steht unter der journalistisch-redaktionellen Verantwortung von
STADA Arzneimittel AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
